Haemovigilance: are there significant differences among plasma products?

Abstract

An analysis of adverse reactions caused by single-donor fresh frozen plasma (FFP) and pooled (solvent/detergent) S/D-treated plasma reveals that these plasma products are significantly different. We are unaware of any reports associating pooled S/D-treated plasma with transfusion-associated acute lung injury, or post-transfusion-thrombocytopenia. In contrast, each of these transfusion reactions is a well-recognized adverse effect of single-donor FFP. Pooled S/D-treated plasma also has a more favorable clinical profile with reference to common acute reactions, such as fever, chills, and allergic reactions, which occur less frequently compared to single-donor FFP.